Alpha Growth PLC Acquisition

RNS Number : 3305D

Alpha Growth PLC

09 September 2024

 

The information communicated within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 (as amended). Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

Alpha Growth plc

("Alpha" or the "Company")

Acquisition of Jeometri Insurance Managers (Guernsey) Limited

Complementary Financial Services Company Strategic Acquisition

 

Alpha Growth plc (LSE: ALGW and OTCQB: ALPGF), a leading financial services specialist in life insurance-linked wealth and asset management, is pleased to announce that it has received regulatory approval and completed its strategic acquisition of 93.36% of the outstanding shares of Jeometri Insurance Managers (Guernsey) Limited ("Jeometri"), with the balance of the shares being retained by its founder and current director, Darren Wadley. Darren Wadley will be continuing as Managing Director of Jeometri and will be responsible for leading the business in its next phase of accelerated growth.

The consideration paid for the acquisition of Jeometri was £449,321 in cash inclusive of the costs of the share acquisition and an infusion of working capital into the business.  The transaction funding has been satisfied from Alpha's existing cash resources and no shares were issued by Alpha for the acquisition.

Joining the Alpha group of companies enhances Jeometri's visibility within the market place and provides it with the support required to accelerate its growth. With Jeometri's advanced solutions and its global clientele, we'll unlock significant opportunities for Alpha's life insurance businesses.

Moreover, Jeometri will deliver services currently provided by third parties for Alpha International Life Assurance Company in Guernsey. This strategic vertical integration will streamline operations, reduce costs, and enhance our efficiency, thereby boosting margins and overall performance for Alpha.

Gobind Sahney, Alpha's Chairman and CEO added: "We are very pleased to have received the Guernsey Financial Services Commission's change of control approval and to be able to expand our insurance services offering in Guernsey.  This strategic acquisition represents a significant opportunity for growth, and we look forward to collaborating with Darren and his team to further grow Jeometri. Together, we aim to deliver complementary, value-enhancing support across the group's businesses.

We are also pleased to share that the group's 'buy strategy' is progressing well, and I look forward to updating our shareholders on our acquisition pipeline in due course.

The board of Alpha remains confident in our ability to achieve our goal of $2 billion in assets under management and administration in 2025. Achieving this goal will deliver significant improvements to both revenue and profitability."

** END **

For more information, please visit www.algwplc.com or contact the following:

 

Alpha Growth plc	[phone]
Gobind Sahney, Executive Chairman	[e-mail]
Allenby Capital Limited	[phone]
Amrit Nahal (Sales and Corporate Broking)
Nick Athanas / Piers Shimwell (Corporate Finance)
UK Investor Relations - Mark Treharne	[e-mail]

 

About Alpha Growth plc

Specialist in Longevity Assets

Alpha Growth plc is a financial advisory business providing specialist consultancy, advisory, and supplementary services to institutional and qualified investors globally in the multi-billion dollar market of longevity assets. Building on its well-established network, the Alpha Growth group has a unique position in the longevity asset services and investment business, as a listed entity with global reach. The group's strategy is to expand its advisory and business services via acquisitions and joint ventures in the UK and the US to attain commercial scale and provide holistic solutions to alternative institutional investors who are in need of specialised skills and unique access to deploy their financial resource in longevity assets.

Longevity Assets and Non-correlation

As a longevity asset, it is non-correlated to the real estate, equity capital and commodity markets.  Its value is a function of time because as time passes the value gets closer to the face value of the policy. Hence creating a steady increase in the net asset value of the investment. This makes it highly attractive to investors wishing to counteract volatility within an investment portfolio and add yield.

Note: The Company only advises on and manages Longevity Assets that originate in the USA where the structured and life settlement market is highly regulated.

Forward Looking Statements Disclaimer

Certain statements, beliefs and opinions in this document are forward-looking, which reflect the Company's or, as appropriate, the Company's directors' current expectations and projections about future events. By their nature, forward-looking statements involve a number of risks, uncertainties and assumptions that could cause actual results or events to differ materially from those expressed or implied by the forward-looking statements. These risks, uncertainties and assumptions could adversely affect the outcome and financial effects of the plans and events described herein. Forward-looking statements contained in this document regarding past trends or activities should not be taken as a representation that such trends or activities will continue in the future. The Company does not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. You should not place undue reliance on forward- looking statements, which speak only as of the date of this document.  Readers should not treat the contents of this document as advice relating to legal, taxation or investment matters, and are to make their own assessments concerning these and other consequences, including the merits of information and the risks.  Readers of this announcement are advised to conduct their own due diligence and agree to be bound by the limitations of this disclaimer.

Important Notice

The content of this announcement has not been approved by an authorised person within the meaning of the Financial Services and Markets Act 2000 (FSMA). This announcement has been issued by and is the sole responsibility of the Company. The information in this announcement is subject to change.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

ACQMZGGLGRZGDZZ